日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and Value of a Centralized Text Message-based Tracking and Support Program for the PRECIDENTD Study

PRECIDENTD 研究集中式短信跟踪和支持程序的开发及其价值

Nelson, Lyndsay A; Bergner, Erin M; Adler, Amos; Yoon, Charles; Mieras, Kathleen; Simeone, Ed; Lema-Driscoll, Jeremy I; Everett, Brendan M; Wexler, Deborah J; Mayberry, Lindsay S

Biomarkers for Atherosclerotic Cardiovascular Events in Rheumatoid Arthritis: Towards Validation of a Biomarker-Enhanced Risk Model

类风湿性关节炎动脉粥样硬化性心血管事件的生物标志物:构建生物标志物增强风险模型的验证

Solomon, Daniel H; Santacroce, Leah; Giles, Jon T; Rist, Pamela; Everett, Brendan M; Liao, Katherine P; Paudel, Misti; Shadick, Nancy A; Weinblatt, Michael; Bathon, Joan M; Demler, Olga

Machine learning for predicting cardiovascular events in older adults with type 2 diabetes using Medicare claims and electronic health records

利用医疗保险索赔数据和电子健康记录,通过机器学习预测老年 2 型糖尿病患者的心血管事件

Htoo, Phyo T; Paik, Julie M; Everett, Brendan M; Glynn, Robert J; Bykov, Katsiaryna; Hahn, Georg; Liu, Jun; Wexler, Deborah J; Patorno, Elisabetta

Comparative Effectiveness of Individual Sodium-Glucose Cotransporter 2 Inhibitors

钠-葡萄糖协同转运蛋白2抑制剂的比较疗效

Shin, HoJin; Paik, Julie M; Everett, Brendan M; DiCesare, Elyse; Alix, Caroline; Glynn, Robert J; Wexler, Deborah J; Patorno, Elisabetta

Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study)

GRADE(2 型糖尿病血糖降低方法:一项比较效果研究)中的心血管结局

Green, Jennifer B; Everett, Brendan M; Ghosh, Alokananda; Younes, Naji; Krause-Steinrauf, Heidi; Barzilay, Joshua; Desouza, Cyrus; Inzucchi, Silvio E; Pokharel, Yashashwi; Schade, David; Scrymgeour, Alexandra; Tan, Meng H; Utzschneider, Kristina M; Mudaliar, Sunder

Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

恩格列净与胰高血糖素样肽-1受体激动剂的心肾疗效比较:EMPRISE研究的最终年结果

Htoo, Phyo T; Tesfaye, Helen; Schneeweiss, Sebastian; Wexler, Deborah J; Everett, Brendan M; Glynn, Robert J; Schmedt, Niklas; Koeneman, Lisette; Déruaz-Luyet, Anouk; Paik, Julie M; Patorno, Elisabetta

Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

更正:恩格列净与胰高血糖素样肽-1受体激动剂的心肾疗效比较:EMPRISE研究的最终年结果

Htoo, Phyo T; Tesfaye, Helen; Schneeweiss, Sebastian; Wexler, Deborah J; Everett, Brendan M; Glynn, Robert J; Schmedt, Niklas; Koeneman, Lisette; Déruaz-Luyet, Anouk; Paik, Julie M; Patorno, Elisabetta

Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus

针对系统性红斑狼疮患者进行个性化心血管风险预测

Choi, May Y; Guan, Hongshu; Yoshida, Kazuki; Paudel, Misti; Kargere, Benjamin A; Li, Daniel; Ellrodt, Jack; Stevens, Emma; Cai, Tianrun; Weber, Brittany N; Everett, Brendan M; Costenbader, Karen H

Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study

钠-葡萄糖协同转运蛋白2抑制剂与西格列汀治疗心力衰竭合并2型糖尿病的比较:一项观察性队列研究

Fu, Edouard L; Patorno, Elisabetta; Everett, Brendan M; Vaduganathan, Muthiah; Solomon, Scott D; Levin, Raisa; Schneeweiss, Sebastian; Desai, Rishi J

Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization

血栓预防对新冠肺炎住院后临床结局的影响

Wang, Tracy Y; Wahed, Abdus S; Morris, Alison; Kreuziger, Lisa Baumann; Quigley, John G; Lamas, Gervasio A; Weissman, Alexandra J; Lopez-Sendon, Jose; Knudson, M Margaret; Siegal, Deborah M; Kasthuri, Raj S; Alexander, Andrew J; Wahid, Lana; Atassi, Bassel; Miller, Peter J; Lawson, Janice W; Patel, Bela; Krishnan, Jerry A; Shapiro, Nancy L; Martin, Deborah E; Kindzelski, Andrei L; Leifer, Eric S; Joo, Jungnam; Lyu, Lingyun; Pennella, Annie; Everett, Brendan M; Geraci, Mark W; Anstrom, Kevin J; Ortel, Thomas L